Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

2.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

3.

After two years, a significant left nasal obstruction was finally diagnosed.

4.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

5.

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot